BridgeMD
New treatment option for Alzheimer Disease
Official title Lifestyle for the BRAin Health - Time Restricted Eating and Mindfulness
ClinicalTrials.gov ID: NCT07042087
What this study is testing
- What it's testing
- The study aims to evaluate the effects of a 9-month intervention combining yoga-based mindfulness techniques, cognitive training, and nutritional counseling on cognitive function, plasma markers of neurodegeneration (tau protein), physical fitness, and metabolism in older adults at increased risk of developing Alzheimer's disease.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 80
You may be able to join if
- Age 60-80 years
- Diagnosis of Subjective Cognitive Impairment (SCI) or Mild Cognitive Impairment (MCI)
- mini-mental-scale (MMSE) score between 24-30
- Positive plasma pTau217 biomarker
- Stable dose of iAChE therapy (if applicable)
You likely can't join if
- Stroke or myocardial infarction within the past year
- Decompensated internal conditions (e.g., severe heart failure, kidney failure, unstable diabetes, GLP1 agonist therapy)
- Long-term psychiatric treatment (except well-managed depression)
- Neurological conditions affecting mobility or cognition (e.g., Parkinson's disease, severe tremor, epilepsy)
- Severe sensory or motor impairment preventing protocol participation
- Active cancer treated within the past 5 years
See the full eligibility criteria
- Age 60-80 years
- Diagnosis of Subjective Cognitive Impairment (SCI) or Mild Cognitive Impairment (MCI)
- mini-mental-scale (MMSE) score between 24-30
- Positive plasma pTau217 biomarker
- Stable dose of iAChE therapy (if applicable)
- Ability to participate in a 9-month intervention
- Stroke or myocardial infarction within the past year
- Decompensated internal conditions (e.g., severe heart failure, kidney failure, unstable diabetes, GLP1 agonist therapy)
- Long-term psychiatric treatment (except well-managed depression)
- Neurological conditions affecting mobility or cognition (e.g., Parkinson's disease, severe tremor, epilepsy)
- Severe sensory or motor impairment preventing protocol participation
- Active cancer treated within the past 5 years
- Poor anticipated compliance (e.g., transport issues, time constraints, non-cooperation)
- Concurrent participation in another clinical study
- Unstable iAChE medication regimen
- Substance or alcohol dependence
The study team makes the final eligibility decision.
Where it's taking place
- Brno, Czechia
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brno, Czechia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.